Sándor Judit
Department of Legal Studies, Central European University , Budapest, Hungary .
Genet Test Mol Biomarkers. 2017 Mar;21(3):140-147. doi: 10.1089/gtmb.2016.0400. Epub 2017 Jan 24.
The law has struggled to justify the unilateral use of individual genomic data, as it could never quite fit either into the narrower data protection or the broader privacy frameworks. This article aims to explore this tension by examining rights and interests of biobank participants.
This article offers a legal analysis, by looking at how the biobank model fits into a privacy rights framework. The Hungarian law is the primary focus of analysis, but reference is made to international legal norms, as well.
The first biobanks were designed with the purpose of achieving collective goals by providing private data from the individual gene donors to scientific research and to the biotechnology industry. The main focus was on data protection. Today, more and more people, however, opt for an active biological citizenship: they want to have access to the results that are relevant to their health. The paternalistic legal attitude does not seem to fit this request to transfer data.
DISCUSSION/CONCLUSION: In the long run, people should have the possibility to contact a biobank and to ask for the return of results. Practical barriers do not constitute a valid argument against the individual's need for disclosure. The law should be on people's side.
法律一直难以证明单方面使用个人基因组数据的合理性,因为它既不完全符合狭义的数据保护框架,也不完全符合广义的隐私框架。本文旨在通过审视生物样本库参与者的权利和利益来探讨这种紧张关系。
本文通过研究生物样本库模式如何融入隐私权框架进行法律分析。分析主要聚焦匈牙利法律,但也参考了国际法律规范。
最初设立生物样本库的目的是通过向科学研究和生物技术产业提供个体基因捐赠者的私人数据来实现集体目标。主要关注点是数据保护。然而如今,越来越多的人选择积极的生物公民身份:他们希望获取与自身健康相关的结果。家长式的法律态度似乎并不符合这种数据转移的要求。
讨论/结论:从长远来看,人们应该有可能联系生物样本库并要求返还结果。实际障碍不能成为反对个人披露需求的有效理由。法律应该站在民众一边。